Archive for the ‘Treatment’ Category

Former WHO Consultant Exposes Ivermectin Takedown

Again, Lyme/MSIDS patients need to understand that when corrupt public health authorities and governmental agencies censor and ban what they consider ‘misinformation,’ patients will be negatively impacted as dissenting opinions will not be allowed.  This has happened for 40 years in Lymeland and now is being seen in COVID. The following information is an important lesson that is imperative to know or we will find ourselves without any help whatsoever from medicine.  As it is, we must find Lyme literate doctors (LLMDs) who defy the accepted narrative that Lyme is hard to catch, and easy to treat and that uses abysmal testing that misses nearly everyone, leaving thousands upon thousands to suffer in silence.  Please share this info widely so people are educated on what is happening.

https://thehighwire.com/videos/former-w-h-o-consultant-exposes-takedown-of-ivermectin/  Video Here (Approx 55 Min)

FORMER W.H.O. CONSULTANT EXPOSES TAKEDOWN OF IVERMECTIN

Del sits down for a one-on-one with the former W.H.O. consultant & research scientist, Tess Lawrie MD, PhD, who was a critical part of the Ivermectin trials over a year ago with overwhelmingly positive conclusions. See data and recorded personal zoom calls that reveal how a key review was attacked from within, keeping the safe, life-saving drug out of the hands of millions of dying Covid patients for more than a year.
This is a mind-blowing expose on how Ivermectin was covered up. There have been too many scenarios, just like this one, where a well-meaning doctor or scientist appears to be doing the right thing, trying to show the truth about the efficacy (or non-efficacy) of a drug, until suddenly, they start acting very strangely, they are no longer being ethical, and won’t admit why.  Money and coercion are typically at the root of these scenarios, and sadly, this is just one more case where – what do you know – as it turns out, The Gates Foundation seems to have been one of the major factors in this cover-up.  Source  (I highly recommend utilizing this sourcelink as there is a plethora of information within it including interviews and data.)
For more:

My Battle & Recovery From Lyme Disease, From the View of My Mother

https://thehive.health/my-lyme-disease-story-from-the-view-of-my-mother/

My Battle and Recovery from Lyme Disease, From The View of My Mother

Debbie + Liz Floyd | The Hive

This article was written by my mother, Debbie Floyd – my biggest health advocate and the woman I learned everything from. This was originally written for Sunlighten Saunas for Lyme Disease Awareness Month. She was the Director of Klinghardt Academy for 10+ years and currently the Director of Discovery Health Solutions – a continuing education program for doctors, nurses and health practitioners. She has helped hundreds of people navigate their dis-ease – and if you’re dealing with Lyme, you know it takes a village.

Here is our story. (See link for article)

__________________

For more:

Live Webinar & Q&A: Lyme, EBV, & More

https://rawlsmd.com/webinars/lyme-ebv-more/

Live Webinar + Q&A: Lyme, EBV, & More

Enduring chronic Lyme disease is bad enough. Add to that a viral coinfection such as Epstein-Barr virus (EBV), cytomegalovirus, or another, and your illness becomes even more severe, plus recovery can take significantly longer. And while viruses like EBV tend to pop up periodically during Lyme treatment, overcoming them is possible — and you don’t have to do it all alone.

Join a live webinar with Dr. Bill Rawls, author of the best-selling book Unlocking Lyme, who knows firsthand what it’s like to struggle with chronic Lyme disease and the viral coinfections that can go hand in hand with it. You’ll discover what really matters when it comes to diagnosing EBV and other viruses, plus the best natural and conventional remedies for easing symptoms and restoring your health.

Since his recovery more than a decade ago, Dr. Rawls has helped thousands of patients find their path to healing from Lyme disease and coinfections. Now, he’d like to help you. Come with your questions, and he’ll answer as many of them as possible. PLUS: Don’t miss an exclusive gift for those who attend the live webinar.

In this webinar, Dr. Rawls will discuss:

What are the telltale signs of EBV?

• Do you need to know which viral coinfection(s) you have before seeking treatment?

• Are there reliable testing methods for EBV and other viruses?

• What are the best herbal and natural remedies for EBV?

• How can you tell for certain when EBV is gone?

• Numerous other insights and answers on EBV and viruses throughout the live Q&A with Dr. Rawls

RESERVE MY SEAT »

Easy & Effective Shield to Protect From COVID

https://articles.mercola.com/sites/articles/archive/2022/02/18/easy-and-effective-shield-from-covid-19

Go here for the 6 minute interview with Dr. Peter McCullough on oral/nasal hygiene for SARS-CoV-2.

An Easy and Effective Shield to Protect From COVID-19

Feb. 18, 2022

Analysis by Dr. Joseph Mercola

Story at-a-glance

  • A simple mouth and nose spray containing povidone iodine (PVP-I) could act as an effective shield to protect against COVID-19
  • PVP-I is a microbicidal agent with a virucidal efficacy of 99.99%
  • When applied, the oronasal spray acts as a protective layer, coating the nasal and oral mucosa, which helps prevent SARS-CoV-2 from binding with ACE2 receptors and gaining entry into your cells
  • In a clinical trial that has not yet been published, a 0.6% PVP-I solution had an efficacy rate of about 81.5% with “almost no mucosal irritation
  • Povidone iodine solutions have been found to inactivate SARS-CoV-2 in as little as 15 seconds and potentially reduce the carriage of infectious SARS-CoV-2 in people with mild to moderate COVID-19
  • Nebulized hydrogen peroxide diluted with normal saline, plus Lugol’s iodine, can also be used for any suspected respiratory infection; the earlier you start, the better

A simple mouth and nose spray could act as an effective shield to protect against COVID-19, adding one more tool to the arsenal of antiviral options. The straightforward solution was recommended by Dr. Mostafa Kamal Arefin of Dhaka Medical College & Hospital in Bangladesh and includes polyvinyl pyrrolidone or povidone iodine (PVP-I), a microbicidal agent with a virucidal efficacy of 99.99%.1

Writing in the Indian Journal of Otolaryngology and Head & Neck Surgery, Arefin recommended the PVP-I oro-nasal spray for health care workers and anyone else to help prevent COVID-19,2 echoing a number of other studies that have also found benefits to gargling, nasal irrigation and nebulization of PVP-I and other compounds, including Lugol’s iodine, saline and hydrogen peroxide.3

How Oronasal Sprays May Shield You From COVID-19

Arefin’s oronasal spray is made of a 0.6% PVP-I solution, kept in a “simple nasal spray device.” The spray formulation works better than drops, he noted, because it allows the active ingredient to diffuse further and reach deeper into the nose and nasopharynx, which is the upper part of the throat behind the nose. When applied, the oronasal spray acts as a protective layer, coating the nasal and oral mucosa.

Typically, if you’re exposed to SARS-CoV-2, it will enter your body through your nose and mouth, remaining there for a time before binding with ACE2 receptors and entering cells. Once inside your cells, the virus has an opportunity to multiply.

“The first step in the development of URTIs [upper respiratory tract infections],” Arefin writes, “is the adherence and colonization of the respiratory pathogen to the nasopharyngeal and oropharyngeal mucosa. Assuming nasal and oral entry of such pathogens, intranasal and intra oral application of Povidone Iodine offers a practical measure for their prevention.”4

By creating a protective shield, oronasal spray helps prevent SARS-CoV-2 from binding with ACE2 receptors and gaining entry into your cells. In a clinical trial that has not yet been published,5 Arefin and colleagues got positive results using 0.6% PVP-I Oro-nasal spray in 189 patients with COVID-19. The 0.6% solution had an efficacy rate of about 81.5%, which was greater than that of other concentrations (0.4% and 0.5%) and produced “almost no mucosal irritation.”6

Povidone-Iodine Inactivates SARS-CoV-2

Already, PVP-I gargles, throat sprays and nasal sprays are available over-the-counter in countries such as Japan and Canada.7 In Japan, a 0.45% PVP-I throat spray is available for the prevention of colds and sore throats, while gargling with the compound is part of their national respiratory guidelines.8

A 2002 study, during which patients were asked to gargle more than four times a day with a PVP-I solution, for several months up to two years, found the practice significantly reduced the incidence of chronic respiratory infections.9 In a preprint study that also advocated for the use of PVP-I nasal sprays and mouthwash to protect health care workers and reduce cross infection during the COVID-19 pandemic, it’s explained:10

“The antimicrobial action of PVP-I occurs after free iodine (I2) dissociates from the polymer complex. Once in the free form, iodine rapidly penetrates microbes and disrupts proteins and oxidizes nucleic acid structures. This interaction ultimately results in microbial death.”

PVP-I has been found to be effective in-vitro against coronaviruses that caused the severe acute respiratory syndrome (SARS) epidemic of 2002 to 2003 and the Middle East respiratory syndrome (MERS) epidemic of 2012 to 2013.11

Povidone iodine solutions have also been found to inactivate SARS-CoV-2 in as little as 15 seconds12 and potentially reduce the carriage of infectious SARS-CoV-2 in people with mild to moderate COVID-19.13 In another study of nasal irrigation among high-risk patients with COVID-19, the use of nasal irrigation with povidone iodine or baking soda reduced the risk of hospitalization by eight times compared to the national rate.14

In a letter to the editor of the Journal of Otolaryngology, Head & Neck Surgery, researchers further noted:15

“Because the reservoir for SARS-CoV-2 shedding is in the nasopharynx and nasal and oral cavities, the application of viricidal agents to these surfaces may reduce virus burden.

Numerous studies have confirmed that povidone-iodine inactivates many common respiratory viruses, including SARS-CoV-1. Povidone-iodine also has good profile for mucosal tolerance. Thus, we propose a prophylactic treatment protocol for the application of topical povidone-iodine to the upper aerodigestive tract.”

Benefits and How to Use PVP-I Oro-Nasal Spray

Using 0.6% PVP-I Oro-nasal spray is low cost, safe and effective against coronaviruses, including SARS-CoV-2. It can be used both in healthy individuals as a protective agent and in people with COVID-19 to reduce viral load and the potential for transmitting the virus to close contacts.

The side effects are minimal and include mucosal irritation, teeth staining and thyroid dysfunction. At least one study, which used both PVP-I mouthwashes and gargles four times a day for five days, found an elevation in thyroid stimulating hormone during treatment, but levels returned to normal after the treatment was stopped.16

Arefin recommends the spray for both health care workers and the general population, prior to attending public gatherings or working outside the home, and following exposure to a suspected COVID-19 patient. He advises two to three puffs in each nostril and one to three puffs in the throat every three to four hours. After every one to two weeks of use, he recommends taking a one-day break from the treatment.17

There are, however, many ways to use nasal irrigation, gargles and nebulization against COVID-19. For instance, Dr. Peter McCullough, an internist, cardiologist and epidemiologist, tweeted, “Nasal/oral viricidal washes can be done prophylactically twice a day and up to every 4 hours during early treatment. Reduce viral load for less severe illness.”18

The Front Line COVID-19 Critical Care Working Group (FLCCC) also recommends povidone-iodine as part of their I-Mask+ protocol for prevention and early outpatient treatment of COVID-19. Part of their prevention protocol includes twice daily gargling with a 1% povidone/iodine solution, while iodine nasal spray or drops are recommended as one of the first line agents in their early treatment protocol. Specifically, they recommend:19

“Use 1 % povidone-iodine commercial product as per instructions 2–3 x daily. If 1 %-product not available, must first dilute the more widely available 10 %-solution and apply 4–5 drops to each nostril every 4 hours. (No more than 5 days in pregnancy.)”

Importantly, povidone-iodine solutions sold as topical skin disinfectants to treat cuts and wounds should not be used for gargling due to potentially harmful ingredients.

Nebulized Hydrogen Peroxide for COVID-19

As I discuss in my interview with Dr. David Brownstein above, he has successfully treated hundreds of COVID-19 patients using immune boosting strategies such as intravenous or nebulized hydrogen peroxide, iodine, oral vitamins A, C and D, and intramuscular ozone. In a case report of 107 confirmed COVID-19 patients that he treated, 91 (85%) used nebulized peroxide diluted with normal saline, plus Lugol’s iodine. As explained in Brownstein’s paper:20

“A solution of 250 cc of normal saline was mixed with 3 cc of 3% hydrogen peroxide providing a final concentration of 0.04% hydrogen peroxide … Additionally, 1 cc of magnesium chloride (200 mg/ml) was added to the 250 cc saline/hydrogen peroxide bag. (This was mixed in the office for the patients.)

Patients were instructed to nebulize 3 cc of the mixture three times per day or more often if there were breathing problems. Usually one or two nebulizer treatments were reported to improve breathing problems … They reported no adverse effects. We have been using nebulized saline/hydrogen peroxide at this concentration for over two decades in his practice.

Hydrogen peroxide is continually produced in the human body with substantial amounts produced in the mitochondria. Every cell in the body is exposed to some level of hydrogen peroxide. The lungs are known to produce hydrogen peroxide. Nebulized hydrogen peroxide has been shown to have antiviral activities. Hydrogen peroxide can activate lymphocytes which are known to be depleted in COVID-19.”

I’ve embraced nebulized peroxide since the COVID-19 pandemic broke out and have received many anecdotal reports from people who have successfully used it, even at more advanced stages. Based on Brownstein’s experience, I also recommend adding iodine when nebulizing, as it appears to make it even more effective.

Proper Dilution Is the Key to Safety

Povidone-iodine gargles and nasal sprays, and nebulized peroxide diluted with saline, with or without iodine, can be safely used by most people both for prevention and in cases of active infection, provided the substances are properly diluted.

For instance, while nebulization with 0.1% to 3% hydrogen peroxide appears to be quite safe, it would be a very serious hazard to use peroxide of greater concentrations. Food grade peroxide up to 35% concentration can be obtained but should NEVER be used topically or internally. It MUST be diluted or severe injury can occur. Your safest bet is to use 3% food grade peroxide and dilute it as indicated in the chart provided below so you end up with a solution of 0.1%.

hydrogen peroxide dilution chart

It’s interesting to note that even nebulizing normal saline may be an effective treatment for acute viral bronchiolitis, a viral infection in the small airways of your lungs.21 So while saline is considered the “inert” substance in the solution — and is often used as a placebo in trials that evaluate nebulized drugs — it may have benefits of its own.

I recommend using nebulized peroxide for any suspected respiratory infection, and the earlier you start, the better. There is no danger in doing it every day if you’re frequently exposed, and there may even be additional beneficial effects, such as a rapid rise in your blood oxygen level.

It is important to understand that this is a protocol that you need to implement BEFORE you attempt to treat COVID. Since early treatment is vital, ideally on Day 1, you want to have the nebulizer and materials already in your house ready to go. I would avoid using a battery powered hand held nebulizer and rather opt for a unit you plug into the wall.

You can find them on eBay or Amazon but make sure they have a face mask and not just a mouthpiece as you want to put the mist into your nose in addition to your lungs as many of the viruses lodge there and if you merely use a mouthpiece you will not reach these viral particles. This is an example of one that plugs in the wall and has a face mask.

Lyme Disease Manifesting as Wenckebach Heart Block

https://danielcameronmd.com/lyme-disease-heart-block-can-progress-rapidly/

Lyme disease and the heart, when AV block progresses rapidly

woman with lyme disease and heart problems sitting on bed

Lyme carditis occurs when Borrelia burgdorferi, the pathogen which causes Lyme disease, burrows into the heart tissue. It’s considered a rare manifestation but can be deadly if not treated promptly. These case reports, featuring an elderly man and young woman, demonstrate just how rapidly a heart block in Lyme carditis can progress.

By Dr. Daniel Cameron

Lyme disease can trigger various heart problems, including Lyme carditis, which typically occurs early on in the disease.  “Lyme carditis is an important reversible cause of heart block, especially in endemic areas,” wrote Aljadba et al. in their article, “Lyme carditis manifesting as Wenckebach heart block.”¹ “Prompt recognition of this potentially lethal condition, with appropriate initiation of antibiotics, can improve clinical outcomes and avoid unnecessary pacemaker implantation.”

72-year-old man: heart block worsens overnight

A 72-year-old man presented to the emergency department with left-sided chest tightness, lightheadedness, presyncope and a mild shortness of breath. While hospitalized, the man’s condition quickly escalated. Overnight, he developed symptomatic bradycardia with his heart rate dropping to 30 – 40 beats per minute.

His initial EKG was normal but a repeat test showed “sinus bradycardia with Mobitz type 1 (Wenckebach) heart block and progressive prolonged PR interval,” the authors wrote.

A Western blot test was positive for Lyme disease with 10 out of 10 bands reactive.

The man was treated successfully with IV ceftriaxone.

“Lyme carditis typically resolves with antibiotic treatment alone and cardiac intervention is often not needed.”¹

After 7 days of treatment with IV antibiotics, the patient’s heart block and bradycardia resolved completely without the need for a temporary pacemaker.

An atrioventricular (AV) block can present with varying degrees of severity. Although an AV block is typically mild, it can progress rapidly, as demonstrated in this case.

“[Lyme carditis] should be on the differential [diagnosis] and appropriate workup done when a patient presents with a heart block, especially in an endemic area.”¹

Lyme carditis may be the initial presenting symptom and typically occurs 1-2 months after the infection.  Although rare, it can also manifest as endocarditis, myocarditis, pericarditis, dilated cardiomyopathy, and heart failure.

33-year-old woman: third-degree heart block within hours

The study, “Lyme Carditis: An Interesting Trip to Third-Degree Heart Block and Back” by Afari and colleagues² demonstrates the importance of reviewing a patient’s travel history during their medical workup and providing prompt treatment.

A young woman, age 33, presented to the emergency department during the summer, complaining of intermittent, dull chest discomfort, which had occurred over a 3-day period. She also exhibited a shortness of breath and lightheadedness.

Three weeks earlier, she had been admitted to the emergency department with photophobia, headache and fever (101.4°F).

READ MORE: 20-year-old camp counselor develops heart block due to Lyme disease 

One month prior to her onset of symptoms, the woman had been hiking in the New Hampshire mountains.

A spinal tap was negative for Lyme disease. But the patient had a 5cm circular EM rash on her neck.

“An initial electrocardiogram showed a first-degree AV block,” the authors wrote. “A presumptive diagnosis of early disseminated phase of Lyme disease was made, and the patient was admitted to the cardiac telemetry floor.”²

Several hours after she was admitted to the hospital, the woman developed second-degree heart block and shortly afterwards, complete heart block.

Lyme disease tests were positive by Western blot. (IgG bands: 28, 30, 39, 41, 45, and 58 and IgM: 39 and 41)

The woman was diagnosed with Lyme disease based on the presence of an EM (erythema migrans) rash and a positive Western blot test.

“As demonstrated in this case, the worsening of the degree of AV block may occur within minutes.”²

After receiving three doses of ceftriaxone, tests revealed that the complete heart block had regressed back to Mobitz Type 1 AV block and then first-degree AV block.

One month after treatment, the patient’s symptoms had completely resolved.

According to the authors, this case highlights:

  • How rapidly the conduction disorder in Lyme carditis can fluctuate; thus it is very important that patients carrying this diagnosis are admitted to the telemetry unit;
  • The importance of considering Lyme disease as an etiology of acute AV nodal conduction disorders in patients who present with cardiac symptoms;
  • The importance of taking a good travel history.

The importance of appropriate and timely therapy to prevent unnecessary interventions such as permanent pacemaker insertion.

References:
  1. Aljadba I, Suresh K, Hussain K M (November 04, 2021) Lyme Carditis Manifesting as Wenckebach Heart Block. Cureus 13(11): e19251. DOI
    10.7759/cureus.19251
  2. Maxwell Eyram Afari, Fady Marmoush, Mobeen Ur Rehman, Umama Gorsi, Joseph F. Yammine, “Lyme Carditis: An Interesting Trip to Third-Degree Heart Block and Back”, Case Reports in Cardiology, vol. 2016, Article ID 5454160, 3 pages, 2016. https://doi.org/10.1155/2016/5454160